Targeted Diagnosis and Treatment of Atrial Fibrillation

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Cardiology".

Deadline for manuscript submissions: 31 March 2025 | Viewed by 276

Special Issue Editors


E-Mail Website
Guest Editor
First Department of Cardiology, Hippocration General Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece
Interests: electrophysiology; arrhythmias; ablation; atrial fibrillation; sudden cardiac death
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Cardiovascular Section, University of Oklahoma, 825 NE 10th St #2E, Oklahoma City, OK 73104, USA
Interests: atrial fibrillation; cardiology; electrocardiography

Special Issue Information

Dear Colleagues,

This Special Issue delves into three pivotal aspects shaping the landscape of modern cardiology, particularly in the realm of atrial fibrillation (AF). It builds upon the growing body of evidence suggesting that autonomic dysfunction contributes to AF development and progression. Additionally, there have been exciting developments in diagnostic tools for AF screening and subclinical AF detection; thus, their impact on AF patient management needs to be determined. Finally, recent advances and novel modalities in AF ablation technology—according to different clinical setting—may enable better ablation outcomes.

Specifically, the primary focus of this Special Issue revolves around the intricate interplay of the autonomic nervous system in AF, shedding light on its nuanced role in the initiation, perpetuation and progression of this common arrhythmia. The intricate connections between autonomic dysregulation and AF provide a deeper understanding of potential therapeutic targets and avenues for intervention.

In addition to exploring the autonomic nervous system, this issue highlights AF screening and subclinical detection. Recognizing the significance of early identification, this issue aims to explore technological advancements in detecting signs of AF that may precede clinical manifestations. An emphasis is placed on novel screening methods, diagnostic tools and their potential impact on preventive strategies, use of anticoagulation and patient outcomes.

Furthermore, this issue extends its scope to the latest breakthroughs in energy sources for AF ablation. Cutting-edge technologies and emerging modalities, including, but not limited to, pulsed field are elucidated, presenting novel approaches that hold promise for improved efficacy and reduced procedural complications in AF ablation. This section aims to provide clinicians and researchers with a nuanced understanding of the evolving landscape of AF ablation techniques.

By synthesizing these three key areas—autonomic nervous system involvement in AF, subclinical AF detection and innovative energy sources for AF ablation—this issue seeks to offer a comprehensive overview of the current state of research and clinical perspectives.

Dr. Dimitris L. Tsiachris
Dr. Stavros Stavrakis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • atrial fibrillation
  • atrial cardiopathy
  • autonomic nervous system
  • pulsed field ablation
  • smart watches
  • antiarrhythmic drugs

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers

This special issue is now open for submission, see below for planned papers.

Planned Papers

The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to MDPI journals are subject to peer-review.

Title: Catheter ablation in atrial fibrillation: recent advances
Authors: Sahib Singh; Lohit Garg; Mohammed Y. Kanjwal; Kevin Bliden; Udaya S Tantry; Paul A Gurbel; M. Chadi Alraies; Abdulla A. Damluji
Affiliation: Department of Medicine, Sinai Hospital of Baltimore, Baltimore, MD, USA
Abstract: Atrial fibrillation (AF) is the leading cause of arrhythmia related morbidity and mortality. Recurrent symptoms, hospitalizations and cost burden to the patients have necessitated treatments beyond antiarrhythmic drugs (AADs) for patients with AF. Catheter ablation has proven effectiveness over medical therapy alone, however the recurrence rates for atrial tachyarrhythmias post ablation remain significant, particularly in patients with persistent and long standing persistent AF. Hence, new techniques for catheter ablation have come up, such as non-thermal energy sources, novel catheters, electroanatomical mapping and ablation of additional targets. In this review, we discuss the recent advances in the field of catheter ablation, including newer modalities for prevention of adverse events and future perspectives.

Title: Atrial fibrillation recurrence after catheter ablation: Predictors, Prevention, and Management
Authors: .
Affiliation: .
Abstract: .

Back to TopTop